Related references
Note: Only part of the references are listed.IDARUCIZUMAB FOR INTRAVENOUS THROMBOLYSIS AND ENDOVASCULAR THROMBECTOMY IN ACUTE STROKE: A CASE REPORT
Yu-Ting Lin et al.
JOURNAL OF EMERGENCY MEDICINE (2020)
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases
Pawel Kermer et al.
INTERNATIONAL JOURNAL OF STROKE (2020)
Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort
P. Alan Barber et al.
NEUROLOGY (2020)
Safety and Outcomes of Intravenous Thrombolysis in Posterior Versus Anterior Circulation Stroke Results From the Safe Implementation of Treatments in Stroke Registry and Meta-Analysis
Boris Keselman et al.
STROKE (2020)
Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke
James Beharry et al.
STROKE (2020)
Dabigatran Reversal With Idarucizumab Preceding Thrombolysis in an Octogenarian Patient with Chronic Kidney Disease and Acute Stroke: A Case Report
Lina C. Laxamana et al.
CLINICAL THERAPEUTICS (2020)
Left atrial appendage thrombus on full-dose dabigatran treatment: a case report
Paolo Candelaresi et al.
EUROPEAN HEART JOURNAL-CASE REPORTS (2020)
Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit
Henry Zhao et al.
INTERNATIONAL JOURNAL OF STROKE (2019)
Reversal of dabigatran with idarucizumab in hyperacute stroke: a new paradigm?
Amy Ting et al.
MEDICAL JOURNAL OF AUSTRALIA (2019)
Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke
Maren Hieber et al.
FRONTIERS IN NEUROLOGY (2019)
Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment
Dawn Meyer et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2019)
Treatment With Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran With Idarucizumab: A Case Study
Sheila Jala et al.
JOURNAL OF NEUROSCIENCE NURSING (2019)
Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan
Chen-Wen Fang et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
Janja Pretnar Oblak et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
Rationale and design of the Registry of Acute Stroke Under Novel Oral Anticoagulants-prime (RASUNOA-prime)
Kirsten Haas et al.
EUROPEAN STROKE JOURNAL (2019)
Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus
Boby V. Maramattom et al.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2019)
Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review
Nathan Thibault et al.
AMERICAN JOURNAL OF THERAPEUTICS (2018)
Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants
E. Touze et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan
Li-Kai Tsai et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience
Daniel Sanak et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review
Yuichiro Ohya et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Idarucizumab-facilitated intravenous thrombolysis in acute stroke with dabigatran: Two cases with hemorrhagic transformation
Yi-Te Tsai et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Intravenous thrombolysis and thrombectomy in stroke after dabigatran reversal by idarucizumab
Aurelien Renard et al.
PRESSE MEDICALE (2018)
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan
Li-Kai Tsai et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience
Daniel Sanak et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review
Yuichiro Ohya et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Intravenous stroke thrombolysis after reversal of dabigatran effect by idarucizumab: first reported case in Hong Kong
W. T. Lo et al.
HONG KONG MEDICAL JOURNAL (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non- vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary
Jan Steffel et al.
KARDIOLOGIA POLSKA (2018)
Intravenous tPA (Tissue-Type Plasminogen Activator ) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke
Chen Jin et al.
STROKE (2018)
Systemic thrombolysis and endovascular thrombectomy in severe acute ischemic stroke after dabigatran reversal with idarucizumab
Quentin Binet et al.
CLINICAL CASE REPORTS (2018)
Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion
H. C. Diener et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
SYSTEMIC THROMBOLYSIS AFTER THE ADMINISTRATION OF IDARUCIZUMAB IN ACUTE ISCHEMIC STROKE
Pasztor Mate et al.
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE (2017)
Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials
George Ntaios et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection
Pawel Kermer et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab
Gary Alvarez Bravo et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Systemic Thrombolysis in Acute Ischemic Stroke after Dabigatran Etexilate Reversal with Idarucizumab-A Case Report
Derya Tireli et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator
David Bissig et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab
Gary Alvarez Bravo et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Systemic Thrombolysis in Acute Ischemic Stroke after Dabigatran Etexilate Reversal with Idarucizumab-A Case Report
Derya Tireli et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator
David Bissig et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Rapid and well tolerated action of idarucizumab for antagonizing dabigatran in a patient needing urgent thrombolysis: a case report
Roberto Facchinetti et al.
BLOOD COAGULATION & FIBRINOLYSIS (2017)
Systemic Thrombolysis for Ischemic Stroke after Antagonizing Dabigatran with Idarucizumab-A Case Report
Niklas Schaefer et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2016)
Idarucizumab elimination of dabigatran minutes before systemic thrombolysis in acute ischemic stroke
Joachim G. Schulz et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab
Joerg Berrouschot et al.
STROKE (2016)
Systemic Thrombolysis for Ischemic Stroke after Antagonizing Dabigatran with Idarucizumab-A Case Report
Niklas Schaefer et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2016)
Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab - a case report
Johannes Sebastian Mutzenbach et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report
Waldemar Kafke et al.
CASE REPORTS IN NEUROLOGY (2016)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
